Skip to main content
SpringerLink
Log in

The protective effect of erdosteine against ototoxicity induced by cisplatin in rats

  • Otology
  • Published:
European Archives of Oto-Rhino-Laryngology and Head & Neck Aims and scope Submit manuscript

Abstract

The elimination of cisplatin ototoxicity is an ongoing concern. This experimental study was undertaken to investigate the effect of oral erdosteine in ameliorating cisplatin-induced ototoxicity. Twenty-eight adult female Wistar albino rats were randomly divided into four equal groups. Group A received an oral carrier vehicle of the drug erdosteine with 0.2 ml of 0.9% saline. Group B was administered only erdosteine (per oral 10 mg/kg twice a day) for 6 days. Group C was injected with cisplatin intraperitoneally (i.p.) on day 0 (16 mg/kg body weight), once only. Group D was given erdosteine (per oral 10 mg/kg/day) 1 day before and for 5 days consecutively after cisplatin injection (16 mg/kg, i.p.). Distortion product otoacoustic emissions (DPOAEs) were elicited in different frequency regions, ranging from 1,001 to 6,299 Hz as DPgram and input/output (I/O) functions from the control and experimental animals. All experimental animals were killed under general anesthesia on day 5, following the last otoacoustic emission measurements. Prior to death, blood samples were drawn for measurement of superoxide dismutase, xanthine oxidase (XO), malondialdehyde and nitric oxide. Initial DPgram and I/O function baseline measurements were similar in all groups prior to any drug administration ( P>0.05). On day 5, intra-subject measurement parameters of DPgrams and I/O functions in the cisplatin group showed significant deterioration ( P <0.05). The other groups revealed no differences between their pre- and post-test drug administration DPgrams and I/O functions at any test frequency ( P>0.05). Comparison of the amplitudes of DPgrams and I/O functions between the cisplatin and control groups showed significant changes ( P <0.05). Biochemical studies noted an increased XO activity following cisplatin administration ( P <0.007). The other biochemical results did not show significant differences between the study and control groups. This study demonstrates that, in rats, erdosteine is protective for cochlear function against the disruptive effects of cisplatin as measured by DPOAEs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Biagi GL, Fregnan GB, Gazzani G, Vandoni G (1989) Erdosteine protection from cigarette smoke-induced loss of alpha 1-antitrypsin activity in rat lungs. Int J Clin Pharmacol Ther Toxicol 27:235–237

    Google Scholar 

  2. Blakley BW, Gupta AK, Myers SF, Schwan S (1994) Risck factor for ototoxicity due to cisplatin. Arch Otolaryngol Head Neck Surg 120:541–546

    Google Scholar 

  3. Braga PC, Dal Sasso M, Zuccotti T (2000) Assessment of the antioxidant activity of the SH metabolite I of erdosteine on human neutrophil oxidative bursts. Arzneimittelforschung 50:739–746

    Google Scholar 

  4. Campbell KC, Rybak LP, Meech RP, Hughes L (1996) D-methionine provides excellent protection from cisplatin ototoxicity in the rat. Hear Res 102:90–98

    Google Scholar 

  5. Campbell KC, Meech RP, Rybak LP, Hughes LF (2003) The effect of D-methionine on cochlear oxidative state with and without cisplatin administration: mechanisms of otoprotection. J Am Acad Audiol 14:144–156

    Google Scholar 

  6. Clerici WJ, Hensley K, DiMartino DL, Butterfield DA (1996) Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants. Hear Res 98:116–124

    Google Scholar 

  7. Cortas NK, Wakid NW (1990) Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 36:1440–1443

    Google Scholar 

  8. Dechant KL, Noble S (1996) Erdosteine. Drugs 52:875–881

    Google Scholar 

  9. de Jongh FE, van Veen RN, Veltman SJ, de Wit R, van der Burg ME, van den Bent MJ, Planting AS, Graveland WJ, Stoter G, Verweij J (2003) Weekly high-dose cisplatin in a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients. Br J Cancer 88:1199–1206

    Google Scholar 

  10. Esterbauer H, Cheeseman KH (1990) Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 186:407–421

    Article  CAS  PubMed  Google Scholar 

  11. Fadillioglu E, Erdogan H (2003) Effects of erdosteine treatment against doxorubicin-induced toxicity through erythrocyte and plasma oxidant/antioxidant status in rats. Pharmacol Res 47:317–322

    Google Scholar 

  12. Fausti SA, Henry JA, Schaffer HI, Olson DJ, Frey RH, Bagby GC Jr (1993) High-frequency monitoring for early detection of cisplatin ototoxicity. Arch Otolaryngol Head Neck Surg 119:661–666

    Google Scholar 

  13. Gazzani G, Fregnan GB, Vandoni G (1989) In vitro protection by erdosteine against oxidative inactivation of alpha-1-antitrypsin by cigarette smoke. Respiration 55:113–118

    Google Scholar 

  14. Huang T, Cheng AG, Stupak H, Liu W, Kim A, Staecker H, Lefebvre PP, Malgrange B, Kopke R, Moonen G, Van de Water TR (2000) Oxidative stress-induced apoptosis of cochlear sensory cells: otoprotective strategies. Int J Dev Neurosci 18:259–270

    Google Scholar 

  15. Inglesi M, Nicola M, Fregnan GB, Bradamante S, Pagani G (1994) Synthesis and free radical scavenging properties of the enantiomers of erdosteine. Farmaco 40:703–708

    Google Scholar 

  16. Irmak MK, Koltuksuz U, Kutlu NO, Yagmurca M, Ozyurt H, Karaman A, Akyol O (2001) The effect of caffeic acid phenethyl ester on ischemia-reperfusion injury in comparison with α-tocopherol in rat kidneys. Urol Res 29:190–193

    Google Scholar 

  17. Koltuksuz U, Irmak MK, Karaman A, Uz E, Var A, Ozyurt H, Akyol O (2000) Testicular nitric oxide levels after unilateral testicular torsion/detorsion in rats pretreated with caffeic acid phenethyl ester. Urol Res 28:360–363

    Google Scholar 

  18. Kopke RD, Liu W, Gabaizadeh R, Jacono A, Feghali J, Sprat D, Garcia P, Steinman H, Malgrange B, Ruben RJ, Rybak L, Van de Water TR (1997) Use of organotypic cultures of Corti’s organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells. Am J Otol 18:559–571

    Google Scholar 

  19. Lopez-Gonzalez MA, Guerrero JM, Rojas F, Delgado F (2000) Ototoxicity caused by cisplatin is ameliorated by melatonin and other antioxidants. J Pineal Res 28:73–80

    Google Scholar 

  20. Miyake K, Kaise T, Hosoe H, Akuta K, Manabe H, Ohmori K (1999) The effect of erdosteine and its reactive metabolite on reactive oxygen species production by inflammatory cells. Inflamm Res 48:205–209

    Google Scholar 

  21. Ozturan O, Jerger J, Lew H, Lynch GR (1996) Monitoring of cisplatin ototoxicity by distortion-product otoacoustic emissions. Auris Nasus Larynx 23:147–151

    Google Scholar 

  22. Prajda N, Weber G (1975) Malignant transformation-linked imbalance: decreased xanthine oxidase activity in hepatomas. FEBS Lett 59:245–249

    Google Scholar 

  23. Ravi R, Somani SM, Rybak LP (1995) Mechanism of cisplatin ototoxicity: antioxidant system. Pharmacol Toxicol 76:386–394

    Google Scholar 

  24. Rybak LP, Kelly T (2003) Ototoxicity: bioprotective mechanisms. Curr Opin Otolaryngol Head Neck Surg 11:328–333

    Google Scholar 

  25. Sakamoto M, Kaga K, Kamio T (2000) Extended high-frequency ototoxicity induced by the first administration of cisplatin. Otolaryngol Head Neck Surg 122:828–833

    Google Scholar 

  26. Sogut S, Zoroglu SS, Ozyurt H, Yilmaz HR, Ozugurlu F, Sivasli E, Yetkin O, Yanik M, Tutkun H, Savas HA, Tarakcioglu M (2003) Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. Clin Chim Acta 331:111–117

    Google Scholar 

  27. Sun Y, Oberley LW, Li Y (1988) A simple method for clinical assay of superoxide dismutase. Clin Chem 34:497–500

    CAS  PubMed  Google Scholar 

  28. Vagliasindi M, Fregnan GB (1989) Erdosteine protection against cigarette smoking-induced functional antiprotease deficiency in human bronchiolo-alveolar structures. Int J Clin Pharmacol Ther Toxicol 27:238–241

    Google Scholar 

  29. Weijl NI, Elsendoorn TJ, Lentjes EG, Hopman GD, Wipkink-Bakker A, Zwinderman AH, Cleton FJ, Osanto S (2004) Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study. Eur J Cancer 40:1713–1723

    Google Scholar 

  30. Wimmer C, Mees K, Stumpf P, Welsch U, Reichel O, Suckfull M (2004) Round window application of D-methionine, sodium thiosulfate, brain-derived neurotrophic factor, and fibroblast growth factor-2 in cisplatin-induced ototoxicity. Otol Neurotol 25:33–40

    Google Scholar 

  31. Yildirim Z, Sogut S, Odaci E, Iraz M, Ozyurt H, Kotuk M, Akyol O (2003) Oral erdosteine administration attenuates cisplatin-induced renal tubular damage in rats. Pharmacol Res 47:149–156

    Google Scholar 

Download references

Acknowledgements

The authors thank Herman Jenkins, MD, of the Department of Otolaryngology, Colorado University, Denver, Colorado, USA, for his help in the preparation of our manuscript. The research was supported by the research fund of Inonu University, Malatya, Turkey.

Author information

Authors and Affiliations

  1. Department of Otorhinolaryngology, Inonu University Medical School, Turgut Ozal Medical Center, 44069, Malatya, Turkey

    M. Tayyar Kalcioglu, Ahmet Kizilay, Erkan Karatas & Orhan Ozturan

  2. Department of Biochemistry, Inonu University Medical School, Malatya, Turkey

    Mukaddes Gulec & Omer Akyol

  3. Department of Pharmacology, Inonu University Medical School, Malatya, Turkey

    Mustafa Iraz

  4. Department of Public Health, Inonu University Medical School, Malatya, Turkey

    Mucahit Egri

Authors
  1. M. Tayyar Kalcioglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ahmet Kizilay
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mukaddes Gulec
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Erkan Karatas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mustafa Iraz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Omer Akyol
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mucahit Egri
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Orhan Ozturan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Tayyar Kalcioglu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kalcioglu, M.T., Kizilay, A., Gulec, M. et al. The protective effect of erdosteine against ototoxicity induced by cisplatin in rats. Eur Arch Otorhinolaryngol 262, 856–863 (2005). https://doi.org/10.1007/s00405-004-0909-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-004-0909-7

Keywords

Search

Navigation